Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Expert Review of Hematology
|
November 19, 2010
Iron overload in myelodysplastic syndromes
Lisa Chodirker, Richard A Wells
Leukemia & Lymphoma
|
October 31, 2006
First among equals: the cancer cell hierarchy
Christine V Ichim, Richard A Wells
Journal of Translational Medicine
|
August 19, 2011
Generation of high-titer viral preparations by concentration using successive rounds of ultracentrifugation
Christine V Ichim, Richard A Wells
Biochemical and Biophysical Research Communications
|
May 25, 2007
Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1
Lap Shu Chan, Richard A Wells
Cancer Treatment Reviews
|
July 2, 2010
5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline
Rena Buckstein, Karen Yee, Richard A Wells, et al.
Leukemia Research
|
May 18, 2006
Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells
Chunhong Gu, Teng Ye, Richard A Wells
PPAR Research
|
January 7, 2010
Cross-Talk between PPARs and the Partners of RXR: A Molecular Perspective
Lap Shu Alan Chan, Richard A Wells
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
January 6, 2016
Myelodysplastic syndrome
Richard A Wells, Rena Buckstein, Jeremy Rezmovitz
Oncogene
|
September 26, 2003
Expression of NPM-RARalpha fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosis
Suzanne Kamel-Reid, Tong Zhang, Richard A Wells
BMC Cancer
|
May 7, 2021
The effects of secondary iron overload and iron chelation on a radiation-induced acute myeloid leukemia mouse model
Lap Shu Alan Chan, Lilly ChunHong Gu, Richard A Wells
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Expert Review of Hematology
|
November 19, 2010
Iron overload in myelodysplastic syndromes
Lisa Chodirker, Richard A Wells
Leukemia & Lymphoma
|
October 31, 2006
First among equals: the cancer cell hierarchy
Christine V Ichim, Richard A Wells
Journal of Translational Medicine
|
August 19, 2011
Generation of high-titer viral preparations by concentration using successive rounds of ultracentrifugation
Christine V Ichim, Richard A Wells
Biochemical and Biophysical Research Communications
|
May 25, 2007
Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1
Lap Shu Chan, Richard A Wells
Cancer Treatment Reviews
|
July 2, 2010
5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline
Rena Buckstein, Karen Yee, Richard A Wells, et al.
Leukemia Research
|
May 18, 2006
Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells
Chunhong Gu, Teng Ye, Richard A Wells
PPAR Research
|
January 7, 2010
Cross-Talk between PPARs and the Partners of RXR: A Molecular Perspective
Lap Shu Alan Chan, Richard A Wells
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
January 6, 2016
Myelodysplastic syndrome
Richard A Wells, Rena Buckstein, Jeremy Rezmovitz
Oncogene
|
September 26, 2003
Expression of NPM-RARalpha fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosis
Suzanne Kamel-Reid, Tong Zhang, Richard A Wells
BMC Cancer
|
May 7, 2021
The effects of secondary iron overload and iron chelation on a radiation-induced acute myeloid leukemia mouse model
Lap Shu Alan Chan, Lilly ChunHong Gu, Richard A Wells
Page
of 6